AC Immune S.A.
ACIU | NASDAQ
$2.65
+$0.02 (+0.76%)
At close: Sep 21, 2026, 4:00 PM ET
$2.65
$0 (+0.19%)
After-hours:
Sep 21, 2026, 7:30 PM ET
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
Revenue | 3.57M | 27.31M | 14.8M | 3.94M | n/a | 15.43M |
Cost of Revenue | n/a | 62.57M | 54.61M | n/a | n/a | 59.49M |
Gross Profit | 3.57M | -35.26M | -39.81M | 3.94M | n/a | -44.06M |
Operating Income | -68.86M | -52.38M | -53.62M | -70.85M | -79.01M | -61.26M |
Interest Income | 1.87M | 3.2M | 1.04M | 69K | 6.49M | 78K |
Pretax Income | -70.45M | -50.91M | -54.22M | -70.74M | -72.99M | -61.92M |
Net Income | -70.45M | -50.92M | -54.23M | -70.75M | -73M | -61.92M |
Selling & General & Admin | 11.65M | 11.43M | 10.58M | 9.58M | 10.88M | 18.56M |
Research & Development | 56.44M | 62.57M | 54.61M | 60.34M | 62.28M | 59.49M |
Other Expenses | 4.35M | -56.89M | -51.36M | 4.86M | 5.85M | -60.84M |
Operating Expenses | 72.44M | 17.12M | 13.82M | 74.78M | 79.01M | 17.2M |
Interest Expense | 191K | 133K | 176K | 355K | 581K | 184K |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 72.44M | 79.69M | 68.43M | 74.78M | 79.01M | 76.69M |
Income Tax Expense | n/a | 3K | 10K | 13K | 3K | n/a |
Shares Outstanding (Basic) | 100.75M | 99.69M | 84.69M | 83.55M | 74.95M | 71.9M |
Shares Outstanding (Diluted) | 100.75M | 99.69M | 84.69M | 83.55M | 74.95M | 71.9M |
EPS (Basic) | -0.70 | -0.51 | -0.64 | -0.85 | -0.97 | -0.86 |
EPS (Diluted) | -0.70 | -0.51 | -0.64 | -0.85 | -0.97 | -0.86 |
EBITDA | -67.75M | -48.62M | -51.83M | -68.03M | -70.01M | -59.73M |
EBIT | -70.26M | -50.78M | -54.05M | -70.39M | -72.41M | -61.26M |
Depreciation & Amortization | 2.5M | 2.16M | 2.22M | 2.36M | 2.41M | 1.54M |
Add to Watchlist
Select watchlists to add or remove ACIU